Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haematopoietic Stem Cell Transplant, Autologous”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Early research (Phase 1)Study completedNCT00574509
What this trial is testing

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 34
Large-scale testing (Phase 3)Study completedNCT00461747
What this trial is testing

GEM05 for Patients With Multiple Myeloma Under 65 Years

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 390
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06931613
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaChildrenNivolumab+1 more
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Study completedNCT00646750
What this trial is testing

Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom

Who this might be right for
Non-Hodgkin's Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 31
Testing effectiveness (Phase 2)Study completedNCT03398200
What this trial is testing

Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma

Who this might be right for
Myeloma
Omar Aljitawi 99
Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Early research (Phase 1)UnknownNCT04309084
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasm, Plasma CellNeoplasms by Histologic Type+17 more
Celularity Incorporated 29
Not applicableStudy completedNCT01111201
What this trial is testing

International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

Who this might be right for
Breast CancerLymphoma
Memorial Sloan Kettering Cancer Center 26
Early research (Phase 1)Study completedNCT02148913
What this trial is testing

Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Corewell Health West 18
Early research (Phase 1)Looking for participantsNCT06647979
What this trial is testing

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)Beta-Thalassemia+1 more
Daniel Bauer 10
Testing effectiveness (Phase 2)Study completedNCT00073918
What this trial is testing

Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+14 more
Fred Hutchinson Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT00005985
What this trial is testing

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Not applicableStudy completedNCT03429387
What this trial is testing

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHaematopoietic Stem Cell Transplant, Autologous+2 more
Peter MacCallum Cancer Centre, Australia 147
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Large-scale testing (Phase 3)Study completedNCT00329030
What this trial is testing

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin
National Heart, Lung, and Blood Institute (NHLBI) 224
Testing effectiveness (Phase 2)Study completedNCT03432364
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT)

Who this might be right for
Transfusion Dependent Beta-thalassemia
Sangamo Therapeutics 5
Testing effectiveness (Phase 2)Ended earlyNCT01468311
What this trial is testing

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Who this might be right for
Hodgkin DiseaseHodgkin Lymphoma
National Cancer Institute (NCI) 6
Load More Results